Low Serotonin Levels Responsible for Cognitive Decline
By MedImaging International staff writers Posted on 23 Aug 2017 |
Image: A brain with a decrease of serotonin transporters (blue) for the whole mild cognitive impairment group, and a brain scan of the whole healthy control group (Photo courtesy of the Gwenn Smith Lab).
New research suggests that serotonin loss may be a key player in cognitive decline in Alzheimer and dementia patients, rather than only a side effect.
The researchers used Positron Emission Tomography (PET) scans of the brain to study the levels of a serotonin transporter in people with mild cognitive problems.
The researchers from the Johns Hopkins University School of Medicine published the study in the September 2017 issue of the journal Neurobiology of Disease. The researchers also concluded that preventing serotonin loss, or using a substitute neurotransmitter, could stop, or slow the progression of Alzheimer's disease, and maybe even other dementias.
The study included 28 participants with mild cognitive impairment, and 28 healthy matched controls. The participants were aged 66 on average, and included about 45% women. All participants underwent a Magnetic Resonance Imaging (MRI), and a PET scan, in order to measure brain structures, and the levels of the serotonin transporter in the brain. The researchers compared the brain imaging results for the serotonin transporter to two memory tests, and found that lower levels of the serotonin transporters correlated with lower scores in the tests.
Psychiatry and behavioral sciences professor, Gwenn Smith, PhD, Johns Hopkins University School of Medicine, said, "Now that we have more evidence that serotonin is a chemical that appears affected early in cognitive decline, we suspect that increasing serotonin function in the brain could prevent memory loss from getting worse and slow disease progression."
Related Links:
Johns Hopkins University School of Medicine
The researchers used Positron Emission Tomography (PET) scans of the brain to study the levels of a serotonin transporter in people with mild cognitive problems.
The researchers from the Johns Hopkins University School of Medicine published the study in the September 2017 issue of the journal Neurobiology of Disease. The researchers also concluded that preventing serotonin loss, or using a substitute neurotransmitter, could stop, or slow the progression of Alzheimer's disease, and maybe even other dementias.
The study included 28 participants with mild cognitive impairment, and 28 healthy matched controls. The participants were aged 66 on average, and included about 45% women. All participants underwent a Magnetic Resonance Imaging (MRI), and a PET scan, in order to measure brain structures, and the levels of the serotonin transporter in the brain. The researchers compared the brain imaging results for the serotonin transporter to two memory tests, and found that lower levels of the serotonin transporters correlated with lower scores in the tests.
Psychiatry and behavioral sciences professor, Gwenn Smith, PhD, Johns Hopkins University School of Medicine, said, "Now that we have more evidence that serotonin is a chemical that appears affected early in cognitive decline, we suspect that increasing serotonin function in the brain could prevent memory loss from getting worse and slow disease progression."
Related Links:
Johns Hopkins University School of Medicine
Latest MRI News
- Diamond Dust Could Offer New Contrast Agent Option for Future MRI Scans
- Combining MRI with PSA Testing Improves Clinical Outcomes for Prostate Cancer Patients
- PET/MRI Improves Diagnostic Accuracy for Prostate Cancer Patients
- Next Generation MR-Guided Focused Ultrasound Ushers In Future of Incisionless Neurosurgery
- Two-Part MRI Scan Detects Prostate Cancer More Quickly without Compromising Diagnostic Quality
- World’s Most Powerful MRI Machine Images Living Brain with Unrivaled Clarity
- New Whole-Body Imaging Technology Makes It Possible to View Inflammation on MRI Scan
- Combining Prostate MRI with Blood Test Can Avoid Unnecessary Prostate Biopsies
- New Treatment Combines MRI and Ultrasound to Control Prostate Cancer without Serious Side Effects
- MRI Improves Diagnosis and Treatment of Prostate Cancer
- Combined PET-MRI Scan Improves Treatment for Early Breast Cancer Patients
- 4D MRI Could Improve Clinical Assessment of Heart Blood Flow Abnormalities
- MRI-Guided Focused Ultrasound Therapy Shows Promise in Treating Prostate Cancer
- AI-Based MRI Tool Outperforms Current Brain Tumor Diagnosis Methods
- DW-MRI Lights up Small Ovarian Lesions like Light Bulbs
- Abbreviated Breast MRI Effective for High-Risk Screening without Compromising Diagnostic Accuracy